Many men and women who have spider veins on their legs, arms and in some areas of the face seek out sclerotherapy treatments that work to damage the cell lining of the blood vessels and make the veins disappear. Asclera injections, a compound made by Merz Aesthetics, has recently been approved by the U.S. Food and Drug Administration and is now being shipped to dozens of physicians’ offices in the United States. Asclera injectiosn have been available in Europe for many years, and have now become available as a spider vein removal treatment in the United States.
According to a study published in the June issue of Phlebology, Asclera is a proven, effective treatment for sclerotherapy and has demonstrated efficacy over other spider vein removal treatment options. The injection is generally well tolerated and has received a high patient satisfaction rating.
Dennis Condon, the President of BioForm Medical, Inc., a Merz Aesthetics company, reports that “The arrival of Asclera has been highly anticipated among physicians, with very positive initial reactions and the number of pre-orders exceeding our expectations…we are proud to finally deliver the next level of cosmetic procedure performance that physicians and patients demand.”
Spider veins are similar to varicose veins in structure, but are much smaller and typically begin as tiny capillaries. They may be blue, purple or red in color, and typically appear on the surface of the calves, ankles, thighs, and sometimes on the face. These veins typically appear in a pattern that looks like small branches on a tree, but may also be linear and appear as thin, separate lines. Sclerotherapy is an in-office procedure that can take just five to 30 minutes, depending on the severity and type of veins being treated. This type of treatment can be painful, but Asclera has proven to cause less pain than traditional treatments.